Histogen
Regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor. Learn more
Launch date
Employees
Market cap
AUD1.4m
Enterprise valuation
(AUD6m) (Public information from Sep 2024)
Share price
$0.22 HSTO
San Diego California (HQ)
Authorizing premium user...